Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis.
Arribas AJ, Napoli S, Cascione L, Sartori G, Barnabei L, Gaudio E, Tarantelli C, Mensah AA, Spriano F, Zucchetto A, Rossi FM, Rinaldi A, Castro de Moura M, Jovic S, Bordone-Pittau R, Di Veroli A, Stathis A, Cruciani G, Stussi G, Gattei V, Brown JR, Esteller M, Zucca E, Rossi D, Bertoni F.
Arribas AJ, et al. Among authors: castro de moura m.
Haematologica. 2022 Nov 1;107(11):2685-2697. doi: 10.3324/haematol.2021.279957.
Haematologica. 2022.
PMID: 35484662
Free PMC article.